AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Nov. 6, 2026

Nexalin Technology, Inc. NXL Stock Forecast

AI-powered price prediction and analysis for Nexalin Technology, Inc. · Alpha · vs marketSwitch to Total

Share
X LinkedIn Reddit WhatsApp Telegram
Embed badge
AI 90-Day Forecast Exact rating locked
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence 16.0% Spearman Correlation (n=345) · 30D 27.0%

See NXL's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

NXL
Fundamentals

Key Statistics

Market Cap$1M
P/B Ratio0.78x
EPS$-0.46
Current Ratio1.25x
D/E Ratio0.98x
Company

About Nexalin Technology, Inc.

Nexalin Technology, Inc. (NXL) operates within the Industrial Applications and Services sector, specifically in the Electromedical & Electrotherapeutic Apparatus industry.

Industrial Applications and Services Electromedical & Electrotherapeutic Apparatus Nasdaq Small Cap
News

Latest News

  • Loading...

Where NXL sits on the market map

Industrial Applications and Services · Electromedical & Electrotherapeutic Apparatus
Explore the map →
Industry Peers

Electromedical & Electrotherapeutic Apparatus Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
NXL Nexalin Technology, Inc. $1M –
MDT Medtronic Plc $134.10B 25.8x
LIVN Livanova Plc $5.02B 34.9x
ITGR Integer Holdings Corp $4.31B 43.7x
AXGN Axogen, Inc. $2.91B –
TMDX Transmedics Group, Inc. $2.39B 18.4x
CNMD Conmed Corp $1.57B 19.6x
CBLL Ceribell, Inc. $998M –
INMD Inmode Ltd. $770M 6.8x
CV Capsovision, Inc $310M 7.4x
ELMD Electromed, Inc. $224M 20.6x
FOCL Edap Tms Sa $159M –
STXS Stereotaxis, Inc. $105M –
VANI Vivani Medical, Inc. $95M –
ECOR Electrocore, Inc. $79M –
OM Outset Medical, Inc. $77M –
NRXS Neuraxis, Inc $77M –
HYPR Hyperfine, Inc. $73M –
POSC Positron Corp $54M –
POCI Precision Optics Corporation, Inc. $51M –
QTI Qt Imaging Holdings, Inc. $30M –
ITOC Itonic Holdings Ltd $12M –
IRIX Iridex Corp $12M –
GTHP Guided Therapeutics Inc $10M –
NDRA Endra Life Sciences Inc. $8M –
ADMT Adm Tronics Unlimited, Inc. $6M –
NUWE Nuwellis, Inc. $2M –
ESMC Escalon Medical Corp $1M 1.5x
YBGJ Yubo International Biotech Ltd N/A –
FAQ

FAQ

Is Nexalin Technology, Inc. a good stock to buy?

Our AI analyzes Nexalin Technology, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are Nexalin Technology, Inc. predictions?

For NXL, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 16.0%, measured on 345 forecast dates between 2022-11-11 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 27.0%, measured on 388 forecast dates between 2022-11-11 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

Nexalin Technology, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of Nexalin Technology, Inc.? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.